L-Arg and NO bioavailability are reduced, NOS2 and ARG2 are overexpressed, the global production of nitrites/nitrates is low, and the serum levels of ADMA and SDMA are increased before the reduction in the eGFR in ADPKD patients. This evidence concerns the gene NOS2 and autosomal dominant polycystic kidney disease.